Table 3.
Indocyanine green lymphangiography stage and excess volume, fat mass, and lean mass.
| Indocyanine green lymphangiography stage | ||||||||
|---|---|---|---|---|---|---|---|---|
| Arm composition | Stage 0 (n = 11) | Stage 1 (n = 11) | Stage 2 (n = 31) | Stage 3 (n = 65) | Stage 4 (n = 77) | Stage 5 (n = 5) | Multivariate linear regression | |
| Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | Coefficient (95%CI) | P-value | |
| Volume (%) | 4.38 ± 6.6 6 | 10.04 ± 6.64 | 10.16 ± 7.27 | 21.49 ± 12.88 | 24.38 ± 14.65 | 14.34 ± 9.52 | 8.15 (5.68; 10.63) | < 0.001 |
| Fat mass (%) | 2.38 ± 17.21 | 9.72 ± 27.83 | 21.55 ± 34.58 | 30.48 ± 31.10 | 48.38 ± 66.06 | 49.79 ± 34.27 | 11.96 (6.28; 17.63) | < 0.001 |
| Lean mass (%) | 6.37 ± 20.41 | 15.30 ± 22.48 | 1.23 ± 24.39 | 20.38 ± 27.86 | 31.14 ± 31.69 | 16.15 ± 27.91 | 6.56 (3.15; 9.98) | < 0.001 |
This table shows the association between lymphangiography lymphedema stage and excess volume, fat mass, and lean mass. The multivariate regression model was adjusted for age, BMI, arm dominance, lymphedema duration, and lymphedema latency. N = number of patients at each stage.
SD standard deviation.